Research Labs | National Cancer Centre Singapore

Cellular & Molecular Research

The Division of Cellular & Molecular Research is focused on understanding the mechanistic basis of tumour development and treatment response; as well as the translation of bench-based findings to devise strategies to improve the early detection and treatment of cancers.

Medical Sciences

The Division of Medical Sciences has evolved in the last decade to one that is completely focused on the mission of translating biological discoveries into the clinic.

Clinical Trials & Epidemiological Sciences

The Division was conceived to provide support and to encourage clinical trials within NCCS.

Research News

Research Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research Precision oncology firm, Lucence, with Diagnostics Development Hub (DxD Hub), hosted by the Agency for Science, Technology and Research (A*STAR), Singapore and the National Cancer Centre Singapore (NCCS), officially launched UNITED 2.0, a S$6 million research collaboration to develop a next-generation, clinical grade cancer profiling test with the goal of advancing the future of precision diagnostics.

13 Mar 2026 Read story

Research 本地人口健康研究完成收集10万人基因数据研究即将进入新阶段本地大规模人口健康研究SG100K已完成收集10万人健康与基因信息的工作，并且进入了基因组测序和分析阶段.

09 Nov 2025 | Lianhe Zaobao Read story

Research New therapy shows promise in treating advanced HER2 mutated lung cancer A global, multicentre, phase 1/2 clinical trial that included clinician-scientists and researchers from MD Anderson Cancer Centre, Seoul National University and the National Cancer Centre Singapore has indicated positive results in treating advanced HER2-mutant non-small-cell lung cancer (NSCLC) with sevabertinib, an oral HER2-targeted tyrosine kinase inhibitor.

21 Oct 2025 Read story

View All News